IO Biotech, Inc. — Director's Dealing 2024

Mar 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2024-03-15

Reporting Person: Burkavage Brian (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-15	Stock Option (Right to Buy)	$1.65	A	50000	Acquired	2034-03-15	Common Stock (50000)	Direct

Footnotes

F1: One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.